Clinical Outcomes improvement of refractory Obsessive compulsive disorder by use Olanazapine | ||
| Al-Qadisiah Medical Journal | ||
| Article 1, Volume 8, Issue 2, December 2012, Pages 221-229 PDF (0 K) | ||
| Author | ||
| Hafidh Mohammed Farhan | ||
| Abstract | ||
| More than half of the patients with obsessive- compulsive disorder (OCD) remain unimproved by Serotonin-Reuptake inhibitors(SSRI). objective of this study was to examine whether addition of atypical antipsychotic (olanzapine ) to Sertraline is useful for patients with OCD who do not respond to SSRI monotherapy. 1. According to (DSM IV-TR criteria) , 20 patients are diagnosed as OCD and did not responded to Sertraline at dose 100-150mg/day 2. Olanazapine was additional treatment , start 2.5mg/day at first month then 5 mg/day for last two months of study . 3. Treatment response was assessed using the Yale-Brown Obsessive-Compulsive Scale (YBOCS) at end of each months of study 16 of 20 patients respond to the olanzapine augmented sertraline therapy . The mean baseline YBOCS score of 32.75 dropped to a mean of 21.75 at endpoint for male with reduction 12.81% from baseline. While in female, the mean baseline YBOCS score of 33.83 dropped to a mean of 21.67 at endpoint with reduction 17.06% from baseline. Treatment-refractory OCD Patients may benefit from addition of olanzapine to ongoing SSRI therapy. | ||
| Keywords | ||
| OCD; Olanazapine; Sertraline; YBOCS | ||
|
Statistics Article View: 62 PDF Download: 66 |
||